Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Epinephrine
Manufacturing
EpiPen rival Kaléo snapped up in $310M deal
EpiPen rival Kaléo was acquired in a $310 million deal by Marathon Asset Management.
Joseph Keenan
Nov 30, 2021 9:35am
Meet Neffy, the kid-friendly epinephrine nasal spray from ARS
Sep 3, 2021 11:27am
Aquestive advances oral epinephrine plan after clearing phase 1
Mar 30, 2021 9:20am
Novartis bolsters Symjepi rollout amid EpiPen shortage
Jul 10, 2019 9:12am
Novartis launches EpiPen challenger at double-digit discount
Jan 17, 2019 10:20am
Novartis, Adamis keep swinging at EpiPen with new Symjepi dose
Sep 28, 2018 11:06am
